Weekly Rundown: I’m Calling BS on Pfizer’s CEO

NEW MONEY CREW
WEEKLY RUNDOWN

Hey, traders, Lance Ippolito here. Welcome to Weekly Rundown, where we'll share some of our top trading ideas — and our biggest winners — from the New Money Crew!

Some of you may be familiar with a new video segment I'm doing that's really catching on where I get to call BS on a particular company and its stock.

And there's some funny business going on with one of this week's hottest companies that everyone has been talking about, Pfizer Inc. (NYSE: PFE).

Monday morning we saw Dow futures up over 1,000 points on possible coronavirus vaccine news from Pfizer. And while this was going on, the CEO was making the rounds to every news outlet calling it one of the biggest medical discoveries of the century. Pfizer stock was up 14% premarket to new highs on the year.

And then… just a couple of days later… news came out that the same guy making the media rounds about Pfizer's fantastic discovery…

Sold 60% of his stock in the company Monday morning. Yep, 60%. And get this; he sold it off just 5 cents from the high.

It's shady, it's fishy, it's eyebrow-raising. If it was such a fantastic discovery, why wouldn't he keep his shares?

In mid-August, Pfizer began its Phase 3 trials for its vaccine candidate, and that's when he started scheming. He knew in August that a vaccine was coming and he not only waited for Pfizer to rally 14%, but he also waited until… after the presidential election to announce his fantastic discovery.

Gang, I am calling total BS on this. And I'll do it again and again. Since then, Pfizer has had red day after red day and will probably fill the gap back to $36 or so.

Moderna executives seem to sell off stock at every pop, and now the CEO of Pfizer is doing the same…

And it's BS.

But now, let's get on to some...

BIG Wins!

We have a couple of big winners to celebrate this week after cashing out a massive 264% profit on Wells Fargo & Co. (NYSE: WFC) out of our New Money Club service. We also bagged a 50% gain on the first half of a trade on Abercrombie & Fitch Co. (NYSE: ANF), and another 67% on the second half of the trade from Weekly Blitz Alerts.

The stock market was red-hot to start the week after news of Pfizer Inc. (NYSE: PFE) and BioNTech's positive COVID-19 vaccine announcement broke Monday morning. Some beaten-down names sprung back to life, putting us in great position!

+50% (first half)/+ 66.67% (second half) on ANF (Dec. 18 $16 CALL).
Entered on Nov. 6 at $1.50 per contract.
Exited first half Nov. 9 at $2.25 a contract for a 50% gain.
Exited second half, also on Nov. 9, at $2.50 a contract for another 66.67%!

Retail stocks have seen bullish flows heading into the holiday season, including Abercrombie and Fitch.

+264% on WFC (Dec. 18 $15 CALL).
Entered on Nov. 2 at $0.22 per contract.
Exited on Nov. 9 at $0.80 per contract for that 263.64% gain!

This WFC pick also was given away free to members right here in the NMC Weekly Rundown, so thanks for reading!

We kick started the week with a bang on these big wins so, guys, If you're not already a member, be sure to check out New Money Club and Weekly Blitz Alerts services to get in on these big wins!

If you have a big score you'd like to share with your fellow New Money Crew readers, email us at wptestimonial@gmail.com.

Start Planning for Wall Street's Algorithmic Takeover

Right now, massive hedge funds, institutions and banks are all gearing up to take over the market with algorithmic trading.

And they plan on leaving you in the dust!

According to CNBC, these algorithms are already dominating over 80% of today's equity market and far outperforming traditional stock-picking strategies.

But there's still hope left for the everyday investor.

Roger Scott has developed an algorithmic trading machine that at-home investors just like you can use without needing to own millions of dollars in upfront capital.

And he's about to reveal the details to it in a never-before-seen presentation.

Sign up to watch the live event today and learn how Roger Scott's Storm can help you not only get ahead of Wall Street … but also supersize your trading account.

Did Gold Futures Just Bottom Out?

Following Monday's positive COVID-19 vaccine news, stocks shot up but gold futures cratered.

So Live Trade Profit's Josh Martinez broke down a trade idea involving gold futures, and he tackled whether futures have bottomed. This of course largely comes down to your philosophy as an investor and a trader.

And Josh believes the markets tend to do the same things around the same price points — they form highs and lows at past highs and lows. So to determine if this week's low was a bottom for the month, simply look at a chart and work your way backward to see if this is an area where it should U-turn.

Looking at a gold futures chart, we see past highs becoming future lows. So if a bottom is going to come, it should have been this week. But where does it go from there?

Josh thinks the gold futures market is set to turn bullish right now. And if you're looking for an entry point, all you need is for the market to create a bullish trend.

What that looks like is a market rally followed by a retrace (a pullback). And then a rally/retrace, and a rally/retrace. The key here is having a low form higher than the previous low. If that happens, more than likely the market is set to rally.

And the bottom level is so far from the top level of the chart that it should create a bullish trend. And in this trend, your buying opportunities come at the retraces mentioned above — buy low, sell high, rinse, repeat!

Be sure and check out Josh's video, where he breaks down the movements for you with his chart.

Signing Off

If you're looking for more compelling trade ideas and stock market musings to read and help you prepare for what lies ahead, here's what other experts at WealthPress are saying:

How Trading has Changed My Life Forever
What to Do When Your Stock Broker Is Down
The Easiest Way to Make Money Trading the Nasdaq

Lance Ippolito
New Money Crew

Disclaimer & Disclosures: The information in this email is intended for informational purposes only and does not guarantee specific results as there is a high degree of risk involved with trading. Also, our traders are real traders and may have financial interests in the companies discussed. Please see our Terms and Conditions for more information.

Past performance is no guarantee of future results. There is a high degree of risk involved in trading. For our full disclaimer, visit here.

Weekly Rundown: I’m Calling BS on Pfizer’s CEO

0 Response to "Weekly Rundown: I’m Calling BS on Pfizer’s CEO"

Post a Comment